- Report
- April 2026
- 379 Pages
Global
From €5158EUR$5,850USD£4,482GBP
- Report
- January 2026
- 180 Pages
Global
From €3967EUR$4,500USD£3,448GBP
- Report
- January 2026
- 185 Pages
Global
From €3967EUR$4,500USD£3,448GBP
- Report
- June 2025
- 150 Pages
Global
From €2380EUR$2,699USD£2,068GBP
- Report
- June 2025
- 200 Pages
Global
From €2459EUR$2,789USD£2,137GBP
- Report
- March 2026
- 197 Pages
Global
From €4404EUR$4,995USD£3,827GBP
- Report
- February 2026
- 200 Pages
Global
From €4404EUR$4,995USD£3,827GBP
- Report
- February 2026
- 191 Pages
Global
From €4404EUR$4,995USD£3,827GBP
- Report
- August 2025
- 150 Pages
Global
From €4276EUR$4,850USD£3,716GBP
- Report
- July 2025
- 150 Pages
Global
From €4276EUR$4,850USD£3,716GBP
- Report
- February 2026
- 160 Pages
Global
From €2927EUR$3,320USD£2,544GBP
€3659EUR$4,150USD£3,180GBP
- Report
- May 2025
- 134 Pages
Global
From €15865EUR$17,995USD£13,787GBP
- Report
- August 2025
- 98 Pages
Global
From €4276EUR$4,850USD£3,716GBP
- Report
- April 2026
- 50 Pages
Global
From €2336EUR$2,650USD£2,030GBP
- Report
- April 2026
- 50 Pages
Global
From €2336EUR$2,650USD£2,030GBP
- Report
- April 2026
- 50 Pages
Global
From €2336EUR$2,650USD£2,030GBP
- Report
- April 2026
- 50 Pages
Global
From €2336EUR$2,650USD£2,030GBP
- Report
- April 2026
- 50 Pages
Global
From €2336EUR$2,650USD£2,030GBP
- Report
- January 2026
Global
From €6612EUR$7,500USD£5,746GBP
- Report
- July 2024
- 288 Pages
Global
From €5181EUR$6,082USD£4,350GBP

The HIV/AIDS Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs to treat HIV/AIDS. These drugs are used to treat the virus itself, as well as the symptoms and complications associated with it. HIV/AIDS drugs are typically divided into two categories: antiretroviral drugs, which are used to suppress the virus, and prophylactic drugs, which are used to prevent the transmission of the virus.
The HIV/AIDS Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Gilead Sciences, Merck, GlaxoSmithKline, Bristol-Myers Squibb, and Pfizer. These companies are constantly developing new drugs and treatments to improve the quality of life for those living with HIV/AIDS. Show Less Read more